Tarasi Rocco F. III 4
4 · CNO Financial Group, Inc. · Filed Jun 11, 2026
Research Summary
AI-generated summary of this filing
CNO Financial (CNO) CMO Rocco F. Tarasi III Sells Shares & Exercises Options
What Happened
Rocco F. Tarasi III, Chief Marketing Officer of CNO Financial Group (CNO), exercised stock options to acquire 5,750 shares (cost $121,095) and sold a total of 9,058 shares in open-market transactions for gross proceeds of $449,592. The sales include a 3,308-share sale on June 10 and a 5,750-share sale on June 11. The pattern shows an option exercise followed by an immediate sale of the resulting shares.
Key Details
- Transactions:
- 2026-06-10: Sold 3,308 shares at $49.00 — proceeds $162,092 (open market sale).
- 2026-06-11: Exercised/converted derivative to acquire 5,750 shares at $21.06 — cost $121,095 (code M).
- 2026-06-11: Sold 5,750 shares at $50.00 — proceeds $287,500 (open market sale).
- 2026-06-11: A secondary derivative entry shows disposition of the option instrument at $0.00 (reflects the option being exercised/terminated).
- Aggregate: Gross sale proceeds = $449,592; exercise cost = $121,095; approximate pre-tax cash difference ≈ $328,497 (does not account for taxes/fees).
- Shares owned after transaction: not stated in the provided filing details.
- Footnotes: 3,308-share sale executed under a Rule 10b5-1 trading plan adopted Feb 24, 2026 (F1). The exercised options vested in two tranches (Feb 23, 2019 and Feb 23, 2020) (F2).
- Timeliness: No late filing indication provided in the supplied data.
Context
The filing shows an option exercise (code M) followed by immediate open-market sales — a common cashless outcome where an insider pays the exercise price, receives shares, and sells them. The 3,308-share sale was executed under a pre-established 10b5-1 plan, which generally indicates a pre-set schedule rather than ad-hoc trading decisions. These transactions are factual disclosures and do not, by themselves, indicate management sentiment about the company’s prospects.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-06-10$49.00/sh−3,308$162,092→ 79,191 total - Exercise/Conversion
Common Stock
2026-06-11$21.06/sh+5,750$121,095→ 84,941 total - Sale
Common Stock
[F1]2026-06-11$50.00/sh−5,750$287,500→ 79,191 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F2]2026-06-11−5,750→ 0 totalExercise: $21.06Exp: 2027-02-23→ Common Stock (5,750 underlying)
Footnotes (2)
- [F1]Shares sold pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2026.
- [F2]One-half of the stock options vested and became exercisable on February 23, 2019, and one-half vested and became exercisable on February 23, 2020.